业务年度拜耳简介

业务年度拜耳简介20082009用创新科技使生活充满活力请用正楷字体填写姓名地址邮编城市电子邮箱电话版本2008/2009•E9100591870邮票(可选)回复卡BayerAGc/oFingerMarketingServicesPostfach10053841405NeussGermany首页TonyBeckKyleGross前瞻性声明刊头拜耳股份有限公司，企业公关传媒部，德国勒沃库森51368Dr.KatrinSchnerider，电话[phone]电子邮箱：[e-mail]&Co.OHG提供语言服务月请给我邮寄以下的拜耳集团出版物：《年度报告》□德语□英语《股东通讯》□德语□英语《可持续发展报告》□德语□英语《报道》－拜耳企业杂志□德语□英语《研究》－拜耳科研杂志□德语□英语姓名，数据，信息□德语□英语□请发送指定刊物的最新版本□请将我的名字录入刊物邮寄目录姓名︱数据︱信息2008︱2009目录45..............................................................................2..............................................................................4..............................................................................6.................................................................................8...............................................................10.............................................................................12.........................................................................14.....................................................................16......................................................................20......................................................................24.............................................................................28....................................................................................30.............................................................................32.......................................................34....................................................................................38....................................................................................42....................................................................................44目录业务年度拜耳简介以创新与发展创造价值拜耳是一家在医药保健、作物营养、高科技材料领域拥有核心竞争力的全球性企业。我们坚持以人为本，以自身产品与服务提升人类生活品质；同时致力于以创新、成长与高盈利能力创造更多价值。2企业信条3业务年度拜耳简介拜耳集团企业使命组织结构拜耳股份有限公司(CorporateCenter)组织结构图拜耳股份有限公司（控股公司）集团董事会•WernerWenning•*RichardPott*•KlausKühn•WolfgangPlischke企业中心部门JörgKrellMichaelSchadeAlexanderRosarRainerMeyerJanPetersJohannesDietschMatthiasMangoldRolandHartwigWolfgangGrosseEntrupUlrichHauckFranz-JosefBerners*4组织结构业务领域拜耳医药保健ArthurJ.HigginsLykelevanderBroekGaryBalkemaSandraE.Peterson**UlrichKöstlin**GunnarRiemannWernerBaumann*HartmutKlusik**AndreasBusch**KemalMalik拜耳作物科学FriedrichBerschauerRüdigerScheitza*AlexanderKlausenerFranz-JosefPlackeQHSEWolfgangWelterDirkSuwelackBerndNaafTAMECIS()JacquesduPuyWilliamBucknerMarcReichardtPascalHoussetJoachimSchneider拜耳材料科技PatrickThomasAxelSteiger-BagelTonyVanOsselaer*GünterHilkenPeterVanackerJoachimWolffTimBielfeldt服务领域拜耳商务服务AndreasReschNorbertFieseler*拜耳技术服务AchimNoackCURRENTAKlausSchäferJoachimWaldi*5**业务年度拜耳简介运营地点北美销售额.........................................81.61(4.9)*员工.............................................16,800研发投入......................................5.81公司.............................................47**拉美/非洲/中东销售额.........................................46.60(19.0)*员工.............................................14,300研发投入......................................3500公司.............................................51***20071231**(20071231)6运营地点亚太销售额...........................................52.11(13.0)*员工...............................................18,900研发投入.......................................1.26公司..............................................60**欧洲销售额..........................................143.53(13.4)*员工..............................................56,200研发投入.......................................18.36公司数...........................................168**业务年度拜耳简介拜耳股份有限公司董事会沃纳•温宁20024••194619661997220052007(GermanChemicalIndustryAssociation)乌•普利思博士•19511980Miles2000200632007128董事会9里•鲍特博士••19531984199920025拜耳股份有限公司董事会凯•库恩••1952,19781998200259业务年度拜耳简介监事会，企业管理20GermanCo-determinationAct企业管理10监事会，企业管理监事会成员ürgenWeberProf.Dr.Dr.h.c.Ernst-LudwigWinnackerOliverZühlke2007集团销售额200711.8%323.852006289.56*20066236.1%7.3%5.6%6.2%运营绩效2007EBITDA67.7724.1%200655.84EBITDA20.9%2007EBIT42.87*8.7147.84200639.139.0%42.81200639.282008年度展望20085%EBITDAEBITDA商业动态*12商业动态拜耳作物科学18%拜耳集团20062007年%28,95632,38511.8EBITDA14,6755,86625.5EBITDA5,5846,77721.4EBIT22,7623,15414.2EBIT3,4794,28723.21,9802,23412.81,6834,711•()32.225.84•43,9134,78422.353,9284,2819.0*1,7391,8918.72,2972,57812.2()1.001.3535.0*200744,对账4%拜耳医药保健46%13拜耳集团关键数据业务年度拜耳简介200753.8%20075156.8%DAX3020082007Nexavar®Xarelto®德国股票市场200721%8,00020078,06722.3%每股股息35%1.3510.3220072.2%投资者信息14投资者信息指数(1